Trial Outcomes & Findings for Validation Study of Mean Arterial Pressure (MAP) Parameter of Masimo INVSENSOR00073 (NCT NCT06334055)
NCT ID: NCT06334055
Last Updated: 2025-07-10
Results Overview
Accuracy and precision of mean arterial pressure (MAP) measured by Masimo INVSENSOR00073 in comparison to radial arterial line.
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
101 participants
Primary outcome timeframe
1-5 hours.
Results posted on
2025-07-10
Participant Flow
Participant milestones
| Measure |
Masimo INVSENSOR00073
All subjects who are enrolled into the test group and participate in data collection receive the noninvasive Masimo INVSENSOR00073 sensor.
Masimo INVSENSOR00073: Noninvasive blood pressure monitor
|
|---|---|
|
Overall Study
STARTED
|
101
|
|
Overall Study
COMPLETED
|
25
|
|
Overall Study
NOT COMPLETED
|
76
|
Reasons for withdrawal
| Measure |
Masimo INVSENSOR00073
All subjects who are enrolled into the test group and participate in data collection receive the noninvasive Masimo INVSENSOR00073 sensor.
Masimo INVSENSOR00073: Noninvasive blood pressure monitor
|
|---|---|
|
Overall Study
Adverse Event
|
4
|
|
Overall Study
Disqualified
|
72
|
Baseline Characteristics
Validation Study of Mean Arterial Pressure (MAP) Parameter of Masimo INVSENSOR00073
Baseline characteristics by cohort
| Measure |
Test Subject
n=25 Participants
All subjects who are enrolled into the test group and participate in data collection receive the noninvasive Masimo INVSENSOR00073 sensor.
Masimo INVSENSOR00073: Noninvasive blood pressure monitor
|
|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
25 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=5 Participants
|
|
Sex: Female, Male
Female
|
5 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
20 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
5 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
5 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
7 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
2 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
6 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
25 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 1-5 hours.Population: 9 subjects not analyzed due to incorrect software version
Accuracy and precision of mean arterial pressure (MAP) measured by Masimo INVSENSOR00073 in comparison to radial arterial line.
Outcome measures
| Measure |
Masimo INVSENSOR00073
n=16 Participants
All subjects who are enrolled into the test group and participate in data collection receive the noninvasive Masimo INVSENSOR00073 sensor.
Masimo INVSENSOR00073: Noninvasive blood pressure monitor
|
|---|---|
|
Mean Arterial Pressure (MAP) Accuracy and Precision of Masimo INVSENSOR00073
|
1.38 Millimeters of mercury (mmHg)
Standard Deviation 4.98
|
Adverse Events
Masimo INVSENSOR00073
Serious events: 0 serious events
Other events: 10 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
Masimo INVSENSOR00073
n=101 participants at risk
All subjects who are enrolled into the test group and participate in data collection receive the noninvasive Masimo INVSENSOR00073 sensor.
Masimo INVSENSOR00073: Noninvasive blood pressure monitor
|
|---|---|
|
Injury, poisoning and procedural complications
Venous sample complications
|
4.0%
4/101 • 1-5 hours
|
|
Injury, poisoning and procedural complications
Arterial line complications
|
2.0%
2/101 • 1-5 hours
|
|
Injury, poisoning and procedural complications
Infusion effects
|
4.0%
4/101 • 1-5 hours
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place